Clinical Trial Update: Therapy for Advanced NSCLC With EGFR 19delins Mutation [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) study of an investigational therapy for advanced non-small cell lung cancer with EGFR 19delins mutation. The trial is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Investigational EGFR 19delins NSCLC therapy

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Lung Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING